Trial Updates

LUMEVOQ gene therapy for LHON 2:40
LUMEVOQ gene therapy for LHON
Magali Taiel • 6 Oct 2021
ProTrans: Wharton’s jelly-derived MSC therapy for type I diabetes 2:13
ProTrans: Wharton’s jelly-derived MSC therapy for type I diabetes
Lindsay Davies • 7 Jun 2021
Cord blood infusion in children with autism spectrum disorder 6:25
Cord blood infusion in children with autism spectrum disorder
Joanne Kurtzberg • 22 Jun 2021
ATA188: an allogeneic EBV-specific T cell therapy for progressive MS 5:20
ATA188: an allogeneic EBV-specific T cell therapy for progressive MS
Jakob Dupont • 17 Jun 2021
Umbilical cord blood infusions in children with cerebral palsy 4:44
Umbilical cord blood infusions in children with cerebral palsy
Joanne Kurtzberg • 22 Jun 2021
ATA188 in EBV+ progressive multiple sclerosis 2:58
ATA188 in EBV+ progressive multiple sclerosis
Pascal Touchon • 7 Apr 2021
SPEARHEAD-1: ADP-A2M4 in synovial sarcoma and MRCLS 1:09
SPEARHEAD-1: ADP-A2M4 in synovial sarcoma and MRCLS
Jo Brewer • 7 Apr 2021
SURPASS: evaluating the next-generation of SPEAR T-cell therapy 1:22
SURPASS: evaluating the next-generation of SPEAR T-cell therapy
Jo Brewer • 7 Apr 2021
hESC-derived RPE for dry AMD 3:21
hESC-derived RPE for dry AMD
Jane Lebkowski • 8 Apr 2021
Off-the-shelf cell therapy for bone indications: ALLOB & JTA-004 4:54
Off-the-shelf cell therapy for bone indications: ALLOB & JTA-004
Miguel Forte • 26 May 2021
Allogenic NKX101 in r/r AML 2:56
Allogenic NKX101 in r/r AML
James Trager • 22 Feb 2021
CTNS-RD-04: HSC gene therapy for cystinosis 7:49
CTNS-RD-04: HSC gene therapy for cystinosis
Stephanie Cherqui • 17 May 2021
iPSC-derived RPE for macular degeneration 3:32
iPSC-derived RPE for macular degeneration
Masayo Takahashi • 26 May 2021
IL-1Ra gene therapy for knee OA: interim Phase I results 3:02
IL-1Ra gene therapy for knee OA: interim Phase I results
Christopher Evans • 19 May 2021
Lentiviral gene therapy for pyruvate kinase deficiency 3:13
Lentiviral gene therapy for pyruvate kinase deficiency
Jose-Carlos Segovia • 12 May 2021
AVR-RD-01: ex vivo lentiviral gene therapy for Fabry disease 3:52
AVR-RD-01: ex vivo lentiviral gene therapy for Fabry disease
Mark Thomas • 11 May 2021
The content of VJRegenMed is intended for healthcare professionals